The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-acetamido-6-amino-N-((2S,3S)-1-(((2S,3R)-1-(((S)-1-(((S)-1-(cyclopropylamino)-1,2-dioxopentan-3-yl)amino)-1-oxopropan-2-yl)amino)-3-hydroxy-1-oxobutan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)hexanamide Hydrochloride ID: ALA5205624
PubChem CID: 168296005
Max Phase: Preclinical
Molecular Formula: C29H52ClN7O8
Molecular Weight: 625.77
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)CC)[C@@H](C)O)C(=O)C(=O)NC1CC1.Cl
Standard InChI: InChI=1S/C29H51N7O8.ClH/c1-7-15(3)22(35-26(41)21(32-18(6)38)11-9-10-14-30)27(42)36-23(17(5)37)28(43)31-16(4)25(40)34-20(8-2)24(39)29(44)33-19-12-13-19;/h15-17,19-23,37H,7-14,30H2,1-6H3,(H,31,43)(H,32,38)(H,33,44)(H,34,40)(H,35,41)(H,36,42);1H/t15-,16-,17+,20-,21-,22-,23-;/m0./s1
Standard InChI Key: RGVLEAIBFYBMTD-PEFJUNQQSA-N
Molfile:
RDKit 2D
45 44 0 0 0 0 0 0 0 0999 V2000
5.9398 -1.9629 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-5.0577 0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3432 0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0577 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3430 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3430 -1.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6284 -2.0629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6284 -2.8881 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.7724 0.8253 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4870 0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.2015 0.8253 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.4870 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3432 1.6504 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6286 0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9140 0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1993 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9140 1.6504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6286 2.0629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1993 2.0629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6286 2.8881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4846 0.8251 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1993 -0.4126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.7700 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0553 0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7700 -0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0553 -0.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4846 -0.8252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0553 1.6504 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6592 0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3738 0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0884 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3738 1.6504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8032 0.8251 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0884 -0.4126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5178 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2325 0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5178 -0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2325 1.6504 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9471 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6617 0.8251 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9471 -0.4126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3764 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2325 -0.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7898 -0.3034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2015 0.4116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 4 1 6
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
2 9 1 0
9 10 1 0
10 11 2 0
10 12 1 0
3 13 2 0
3 14 1 0
14 15 1 0
15 16 1 1
15 17 1 0
17 18 1 0
17 19 1 6
18 20 1 0
16 21 1 0
16 22 2 0
21 23 1 0
23 24 1 6
23 25 1 0
25 26 1 0
25 27 1 1
24 28 2 0
24 29 1 0
29 30 1 0
30 31 1 0
30 32 1 1
31 33 1 0
31 34 2 0
33 35 1 0
35 36 1 0
35 37 1 6
36 38 2 0
36 39 1 0
39 40 1 0
39 41 2 0
40 42 1 0
37 43 1 0
44 42 1 0
44 45 1 0
42 45 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 625.77Molecular Weight (Monoisotopic): 625.3799AlogP: -1.74#Rotatable Bonds: 20Polar Surface Area: 237.92Molecular Species: BASEHBA: 9HBD: 8#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 9#RO5 Violations (Lipinski): 3CX Acidic pKa: 11.61CX Basic pKa: 10.19CX LogP: -1.80CX LogD: -4.24Aromatic Rings: ┄Heavy Atoms: 44QED Weighted: 0.06Np Likeness Score: 0.10
References 1. Lidumniece E, Withers-Martinez C, Hackett F, Blackman MJ, Jirgensons A.. (2022) Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery., 65 (19.0): [PMID:36137276 ] [10.1021/acs.jmedchem.2c01093 ]